Chest 2000-02-01

The pharmacological properties of tiotropium.

P J Barnes

Index: Chest 117 , 63S-66S, (2000)

Full Text: HTML

Abstract

Tiotropium is a long-acting anticholinergic drug. Studies with cloned human muscarinic receptors show that tiotropium binds equally well to M(1), M(2), and M(3) receptors. However, it dissociates very slowly from M(1) and M(3) receptors compared with ipratropium, and more rapidly from M(2) receptors. Binding studies with [(3)H]tiotropium in human lung show that it is approximately 10-fold more potent than ipratropium. In vitro, tiotropium has a potent inhibitory effect against cholinergic nerve-induced contraction of airways. It dissociates extremely slowly, compared with the dissociation of atropine and ipratropium. Clinical studies with single doses of inhaled tiotropium confirm that it is a potent and long-lasting bronchodilator. Furthermore, it protects against cholinergic bronchoconstriction for > 24 h. Pharmacokinetic studies show that little of the inhaled drug is absorbed, thus predicting a high margin of safety.

Related Compounds

  • 3-(3-Hydroxy-1-oxo...

Related Articles:

Fast targeted analysis of 132 acidic and neutral drugs and poisons in whole blood using LC-MS/MS.

2014-10-01

[Forensic Sci. Int. 243 , 35-43, (2014)]

Nebulization of active pharmaceutical ingredients with the eFlow(®) rapid: impact of formulation variables on aerodynamic characteristics.

2014-08-01

[J. Pharm. Sci. 103(8) , 2585-9, (2014)]

4R-cembranoid protects against diisopropylfluorophosphate-mediated neurodegeneration.

2014-09-01

[Neurotoxicology 44 , 80-90, (2014)]

Risk factors associated with irreversible airway obstruction in nonsmoking adult patients with severe asthma.

2014-01-01

[Allergy Asthma Proc. 35(5) , 72-9, (2014)]

Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.

2014-10-01

[J. Pharmacol. Exp. Ther. 351(1) , 190-9, (2014)]

More Articles...